Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic effect of Goshajinkigan for paclitaxel/carboplatin-induced peripheral neuropathy
jRCTs021180041Completed
- Start
- Apr 2016
- Countries
- 1
01
Overview
Open-label trial of goshajinkigan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC) and 2 more (2 arms). Primary endpoints: Efficacy of Goshajinkigan on CIPN and Safety of Goshajinkigan. Started Apr 2016; status: completed.
02
Drugs
goshajinkigan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)endometrial cancer (EC)chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on jRCTs021180041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180041.